ArticleOncology letters2024

Efficacy and safety of lenvatinib combined with PD‑1/PD‑L1 inhibitors in the treatment of hepatocellular carcinoma: A meta‑analysis and systematic review.

Baoyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.